ID   PTPRS_HUMAN             Reviewed;        1948 AA.
AC   Q13332; O75255; O75870; Q15718; Q16341; Q2M3R7;
DT   19-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase S;
DE            Short=R-PTP-S;
DE            EC=3.1.3.48 {ECO:0000269|PubMed:8524829, ECO:0000305|PubMed:8992885};
DE   AltName: Full=Receptor-type tyrosine-protein phosphatase sigma;
DE            Short=R-PTP-sigma;
DE   Flags: Precursor;
GN   Name=PTPRS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, FUNCTION,
RP   INTERACTION WITH PPFIA1, ALTERNATIVE SPLICING, TISSUE SPECIFICITY, AND
RP   VARIANT ARG-1457.
RC   TISSUE=Fetal brain;
RX   PubMed=8524829; DOI=10.1073/pnas.92.25.11686;
RA   Pulido R., Serra-Pages C., Tang M., Streuli M.;
RT   "The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-
RT   tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma
RT   isoforms are expressed in a tissue-specific manner and associate with
RT   the LAR-interacting protein LIP.1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:11686-11690(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, ALTERNATIVE SPLICING, AND VARIANT ARG-1457.
RX   PubMed=8992885; DOI=10.1002/jbmr.5650110415;
RA   Endo N., Rutledge S.J., Opas E.E., Vogel R., Rodan G.A., Schmidt A.;
RT   "Human protein tyrosine phosphatase-sigma: alternative splicing and
RT   inhibition by bisphosphonates.";
RL   J. Bone Miner. Res. 11:535-543(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-1457.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ARG-1457.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1503-1589.
RX   PubMed=1370651;
RA   Adachi M., Sekiya M., Arimura Y., Takekawa M., Itoh F., Hinoda Y.,
RA   Imai K., Yachi A.;
RT   "Protein-tyrosine phosphatase expression in pre-B cell NALM-6.";
RL   Cancer Res. 52:737-740(1992).
RN   [7]
RP   INTERACTION WITH PPFIA1; PPFIA2 AND PPFIA3.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=26231120; DOI=10.1016/j.immuni.2015.07.009;
RA   Bunin A., Sisirak V., Ghosh H.S., Grajkowska L.T., Hou Z.E., Miron M.,
RA   Yang C., Ceribelli M., Uetani N., Chaperot L., Plumas J., Hendriks W.,
RA   Tremblay M.L., Haecker H., Staudt L.M., Green P.H., Bhagat G.,
RA   Reizis B.;
RT   "Protein tyrosine phosphatase PTPRS is an inhibitory receptor on human
RT   and murine plasmacytoid dendritic cells.";
RL   Immunity 43:277-288(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1365-1948.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
RN   [13] {ECO:0000244|PDB:2YD2, ECO:0000244|PDB:2YD3, ECO:0000244|PDB:2YD9}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 30-235, FUNCTION, AND
RP   DISULFIDE BONDS.
RX   PubMed=21454754; DOI=10.1126/science.1200840;
RA   Coles C.H., Shen Y., Tenney A.P., Siebold C., Sutton G.C., Lu W.,
RA   Gallagher J.T., Jones E.Y., Flanagan J.G., Aricescu A.R.;
RT   "Proteoglycan-specific molecular switch for RPTPsigma clustering and
RT   neuronal extension.";
RL   Science 332:484-488(2011).
RN   [14] {ECO:0000244|PDB:4BPC}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1367-1948, AND ACTIVE SITE.
RX   PubMed=23820885; DOI=10.1007/s10059-013-0033-x;
RA   Jeon T.J., Chien P.N., Chun H.J., Ryu S.E.;
RT   "Structure of the catalytic domain of protein tyrosine phosphatase
RT   sigma in the sulfenic acid form.";
RL   Mol. Cells 36:55-61(2013).
RN   [15] {ECO:0000244|PDB:4PBX}
RP   X-RAY CRYSTALLOGRAPHY (3.15 ANGSTROMS) OF 30-614, STRUCTURE BY
RP   ELECTRON MICROSCOPY, INTERACTION WITH NTRK3, GLYCOSYLATION AT ASN-263
RP   AND ASN-308, DISULFIDE BONDS, AND MUTAGENESIS OF ARG-97; ARG-100;
RP   TYR-233 AND 241-ARG-ARG-242.
RX   PubMed=25385546; DOI=10.1038/ncomms6209;
RA   Coles C.H., Mitakidis N., Zhang P., Elegheert J., Lu W., Stoker A.W.,
RA   Nakagawa T., Craig A.M., Jones E.Y., Aricescu A.R.;
RT   "Structural basis for extracellular cis and trans RPTPsigma signal
RT   competition in synaptogenesis.";
RL   Nat. Commun. 5:5209-5209(2014).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-996.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Cell surface receptor that binds to glycosaminoglycans,
CC       including chondroitin sulfate proteoglycans and heparan sulfate
CC       proteoglycan (PubMed:21454754). Binding to chondroitin sulfate and
CC       heparan sulfate proteoglycans has opposite effects on PTPRS
CC       oligomerization and regulation of neurite outgrowth. Contributes
CC       to the inhibition of neurite and axonal outgrowth by chondroitin
CC       sulfate proteoglycans, also after nerve transection. Plays a role
CC       in stimulating neurite outgrowth in response to the heparan
CC       sulfate proteoglycan GPC2. Required for normal brain development,
CC       especially for normal development of the pituitary gland and the
CC       olfactory bulb. Functions as tyrosine phosphatase
CC       (PubMed:8524829). Mediates dephosphorylation of NTRK1, NTRK2 and
CC       NTRK3 (By similarity). Plays a role in down-regulation of
CC       signaling cascades that lead to the activation of Akt and MAP
CC       kinases (By similarity). Down-regulates TLR9-mediated activation
CC       of NF-kappa-B, as well as production of TNF, interferon alpha and
CC       interferon beta (PubMed:26231120). {ECO:0000250|UniProtKB:B0V2N1,
CC       ECO:0000250|UniProtKB:F1NWE3, ECO:0000269|PubMed:21454754,
CC       ECO:0000269|PubMed:26231120, ECO:0000269|PubMed:8524829}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044,
CC       ECO:0000269|PubMed:8524829, ECO:0000305|PubMed:8992885}.
CC   -!- SUBUNIT: Binding to large heparan sulfate proteoglycan structures
CC       promotes oligomerization. Binding to chondroitin sulfate
CC       proteoglycan does not lead to oligomerization (By similarity).
CC       Interacts (via Ig-like domains) with NTRK3 (PubMed:25385546).
CC       Interacts (via Ig-like domains) with NTRK1, but does not form
CC       detectable complexes with NTRK2 (By similarity). Interacts with
CC       PPFIA1, PPFIA2 and PPFIA3 (PubMed:8524829, PubMed:9624153).
CC       {ECO:0000250|UniProtKB:B0V2N1, ECO:0000250|UniProtKB:Q64605,
CC       ECO:0000269|PubMed:8524829, ECO:0000269|PubMed:9624153}.
CC   -!- INTERACTION:
CC       Q16849:PTPRN; NbExp=5; IntAct=EBI-711536, EBI-728153;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26231120};
CC       Single-pass type I membrane protein {ECO:0000305}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:B0V2N1}. Perikaryon
CC       {ECO:0000250|UniProtKB:B0V2N1}. Cytoplasmic vesicle, secretory
CC       vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:Q64605}.
CC       Cell junction, synapse, synaptosome
CC       {ECO:0000250|UniProtKB:Q64605}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000250|UniProtKB:Q64605}. Note=Is rapidly internalized when
CC       dendritic cells are stimulated with the TLR9 ligand cytidine-
CC       phosphate-guanosine (CpG) (PubMed:26231120). Detected in a
CC       punctate pattern along neurites and axon growth cones (By
CC       similarity). {ECO:0000250|UniProtKB:B0V2N1,
CC       ECO:0000269|PubMed:26231120}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=PTPS;
CC         IsoId=Q13332-1; Sequence=Displayed;
CC       Name=PTPS-MEA;
CC         IsoId=Q13332-2; Sequence=VSP_050021;
CC       Name=PTPS-MEB;
CC         IsoId=Q13332-3; Sequence=VSP_050022, VSP_050026, VSP_050027;
CC       Name=PTPS-MEC;
CC         IsoId=Q13332-4; Sequence=VSP_050024;
CC       Name=PTPS-F4-7;
CC         IsoId=Q13332-5; Sequence=VSP_050023, VSP_050025;
CC       Name=2;
CC         IsoId=Q13332-6; Sequence=VSP_050021, VSP_050022, VSP_050024,
CC                                  VSP_050026, VSP_050027;
CC       Name=3;
CC         IsoId=Q13332-7; Sequence=VSP_050021, VSP_050022, VSP_050023,
CC                                  VSP_050025, VSP_050026, VSP_050027;
CC   -!- TISSUE SPECIFICITY: Detected in peripheral blood plasmacytoid
CC       dendritic cells (at protein level) (PubMed:26231120). Detected in
CC       all tissues tested except for placenta and liver (PubMed:8524829,
CC       PubMed:8992885). Detected in peripheral blood plasmacytoid
CC       dendritic cells (PubMed:26231120). {ECO:0000269|PubMed:26231120,
CC       ECO:0000269|PubMed:8524829, ECO:0000269|PubMed:8992885}.
CC   -!- PTM: A cleavage occurs, separating the extracellular domain from
CC       the transmembrane segment. This process called 'ectodomain
CC       shedding' is thought to be involved in receptor desensitization,
CC       signal transduction and/or membrane localization (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2A subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50567.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U35234; AAC50299.1; -; mRNA.
DR   EMBL; U40317; AAC50567.1; ALT_FRAME; mRNA.
DR   EMBL; AC005335; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005790; AAC62832.1; -; Genomic_DNA.
DR   EMBL; AC005338; AAC27825.1; -; Genomic_DNA.
DR   EMBL; AC005788; AAC62834.1; -; Genomic_DNA.
DR   EMBL; AC118535; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW69176.1; -; Genomic_DNA.
DR   EMBL; BC104812; AAI04813.1; -; mRNA.
DR   EMBL; BC143287; AAI43288.1; -; mRNA.
DR   EMBL; S78080; AAB21146.2; -; mRNA.
DR   CCDS; CCDS12139.1; -. [Q13332-7]
DR   CCDS; CCDS12140.1; -. [Q13332-6]
DR   CCDS; CCDS45930.1; -. [Q13332-1]
DR   RefSeq; NP_002841.3; NM_002850.3. [Q13332-1]
DR   RefSeq; NP_570923.2; NM_130853.2. [Q13332-7]
DR   RefSeq; NP_570924.2; NM_130854.2. [Q13332-6]
DR   RefSeq; NP_570925.2; NM_130855.2.
DR   RefSeq; XP_005259663.1; XM_005259606.2. [Q13332-6]
DR   RefSeq; XP_005259666.1; XM_005259609.1. [Q13332-7]
DR   RefSeq; XP_016882554.1; XM_017027065.1. [Q13332-2]
DR   RefSeq; XP_016882555.1; XM_017027066.1. [Q13332-2]
DR   RefSeq; XP_016882556.1; XM_017027067.1. [Q13332-2]
DR   UniGene; Hs.744928; -.
DR   PDB; 2FH7; X-ray; 2.00 A; A=1365-1948.
DR   PDB; 2YD2; X-ray; 2.55 A; A=30-244.
DR   PDB; 2YD3; X-ray; 2.30 A; A=30-235.
DR   PDB; 2YD9; X-ray; 2.60 A; A=30-334.
DR   PDB; 4BPC; X-ray; 2.10 A; A=1367-1948.
DR   PDB; 4PBX; X-ray; 3.15 A; A=30-614.
DR   PDBsum; 2FH7; -.
DR   PDBsum; 2YD2; -.
DR   PDBsum; 2YD3; -.
DR   PDBsum; 2YD9; -.
DR   PDBsum; 4BPC; -.
DR   PDBsum; 4PBX; -.
DR   ProteinModelPortal; Q13332; -.
DR   SMR; Q13332; -.
DR   BioGrid; 111766; 49.
DR   IntAct; Q13332; 17.
DR   MINT; MINT-1349588; -.
DR   STRING; 9606.ENSP00000349932; -.
DR   BindingDB; Q13332; -.
DR   ChEMBL; CHEMBL2396508; -.
DR   DrugBank; DB00630; Alendronic acid.
DR   DrugBank; DB01077; Etidronic acid.
DR   GuidetoPHARMACOLOGY; 1866; -.
DR   DEPOD; Q13332; -.
DR   iPTMnet; Q13332; -.
DR   PhosphoSitePlus; Q13332; -.
DR   BioMuta; PTPRS; -.
DR   DMDM; 317373519; -.
DR   MaxQB; Q13332; -.
DR   PaxDb; Q13332; -.
DR   PeptideAtlas; Q13332; -.
DR   PRIDE; Q13332; -.
DR   DNASU; 5802; -.
DR   Ensembl; ENST00000587303; ENSP00000467537; ENSG00000105426. [Q13332-1]
DR   Ensembl; ENST00000588012; ENSP00000465443; ENSG00000105426. [Q13332-6]
DR   Ensembl; ENST00000592099; ENSP00000467398; ENSG00000105426. [Q13332-7]
DR   GeneID; 5802; -.
DR   KEGG; hsa:5802; -.
DR   UCSC; uc002mbv.3; human. [Q13332-1]
DR   CTD; 5802; -.
DR   DisGeNET; 5802; -.
DR   GeneCards; PTPRS; -.
DR   HGNC; HGNC:9681; PTPRS.
DR   HPA; HPA054747; -.
DR   MIM; 601576; gene.
DR   neXtProt; NX_Q13332; -.
DR   OpenTargets; ENSG00000105426; -.
DR   PharmGKB; PA34026; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00760000118900; -.
DR   HOGENOM; HOG000010250; -.
DR   HOVERGEN; HBG053758; -.
DR   InParanoid; Q13332; -.
DR   KO; K06778; -.
DR   OMA; GGTERCG; -.
DR   OrthoDB; EOG091G11WG; -.
DR   PhylomeDB; Q13332; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-8849932; SALM protein interactions at the synapses.
DR   SIGNOR; Q13332; -.
DR   ChiTaRS; PTPRS; human.
DR   EvolutionaryTrace; Q13332; -.
DR   GeneWiki; PTPRS; -.
DR   GenomeRNAi; 5802; -.
DR   PRO; PR:Q13332; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105426; -.
DR   CleanEx; HS_PTPRS; -.
DR   ExpressionAtlas; Q13332; baseline and differential.
DR   Genevisible; Q13332; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0099061; C:integral component of postsynaptic density membrane; ISS:UniProtKB.
DR   GO; GO:0030285; C:integral component of synaptic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035374; F:chondroitin sulfate binding; ISS:UniProtKB.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; ISS:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0022038; P:corpus callosum development; IEA:Ensembl.
DR   GO; GO:0090557; P:establishment of endothelial intestinal barrier; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0030517; P:negative regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; ISS:UniProtKB.
DR   GO; GO:0048671; P:negative regulation of collateral sprouting; ISS:UniProtKB.
DR   GO; GO:0061000; P:negative regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0032687; P:negative regulation of interferon-alpha production; IMP:UniProtKB.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IMP:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0034164; P:negative regulation of toll-like receptor 9 signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   CDD; cd00063; FN3; 8.
DR   Gene3D; 2.60.40.10; -; 12.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 7.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasmic vesicle; Disulfide bond; Glycoprotein; Heparin-binding;
KW   Hydrolase; Immunoglobulin domain; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Protein phosphatase; Receptor;
KW   Reference proteome; Repeat; Signal; Synapse; Synaptosome;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30   1948       Receptor-type tyrosine-protein
FT                                phosphatase S.
FT                                /FTId=PRO_0000025462.
FT   TOPO_DOM     30   1282       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1283   1303       Helical. {ECO:0000255}.
FT   TOPO_DOM   1304   1948       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       33    123       Ig-like C2-type 1.
FT   DOMAIN      135    233       Ig-like C2-type 2.
FT   DOMAIN      245    327       Ig-like C2-type 3.
FT   DOMAIN      334    424       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      429    523       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      527    616       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      621    718       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      723    831       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      832    930       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      931   1033       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1036   1120       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1393   1648       Tyrosine-protein phosphatase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   DOMAIN     1680   1939       Tyrosine-protein phosphatase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION       68     72       Important for binding to
FT                                glycosaminoglycan chains.
FT                                {ECO:0000250|UniProtKB:B0V2N1}.
FT   REGION     1589   1595       Substrate binding. {ECO:0000250}.
FT   COMPBIAS    641    644       Poly-Pro.
FT   ACT_SITE   1589   1589       Phosphocysteine intermediate.
FT                                {ECO:0000305|PubMed:23820885}.
FT   ACT_SITE   1880   1880       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   BINDING    1557   1557       Substrate. {ECO:0000250}.
FT   BINDING    1633   1633       Substrate. {ECO:0000250}.
FT   SITE       1197   1198       Cleavage. {ECO:0000250}.
FT   CARBOHYD    263    263       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4PBX,
FT                                ECO:0000269|PubMed:25385546}.
FT   CARBOHYD    308    308       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4PBX,
FT                                ECO:0000269|PubMed:25385546}.
FT   CARBOHYD    733    733       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    940    940       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     54    107       {ECO:0000244|PDB:2YD2,
FT                                ECO:0000244|PDB:2YD3,
FT                                ECO:0000244|PDB:2YD9,
FT                                ECO:0000244|PDB:4PBX,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:21454754,
FT                                ECO:0000269|PubMed:25385546}.
FT   DISULFID    156    216       {ECO:0000244|PDB:2YD2,
FT                                ECO:0000244|PDB:2YD3,
FT                                ECO:0000244|PDB:2YD9,
FT                                ECO:0000244|PDB:4PBX,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    266    311       {ECO:0000244|PDB:2YD2,
FT                                ECO:0000244|PDB:2YD3,
FT                                ECO:0000244|PDB:2YD9,
FT                                ECO:0000244|PDB:4PBX,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ     190    198       Missing (in isoform PTPS-MEA, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050021.
FT   VAR_SEQ     236    239       Missing (in isoform PTPS-MEB, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050022.
FT   VAR_SEQ     617   1034       Missing (in isoform PTPS-F4-7 and isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_050023.
FT   VAR_SEQ     784    792       Missing (in isoform PTPS-MEC and isoform
FT                                2). {ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050024.
FT   VAR_SEQ    1035   1035       V -> I (in isoform PTPS-F4-7 and isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_050025.
FT   VAR_SEQ    1350   1365       Missing (in isoform PTPS-MEB, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050026.
FT   VAR_SEQ    1366   1366       S -> G (in isoform PTPS-MEB, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050027.
FT   VARIANT     996    996       T -> M (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs775778266).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035649.
FT   VARIANT    1457   1457       C -> R (in dbSNP:rs4807697).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8524829,
FT                                ECO:0000269|PubMed:8992885,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_047277.
FT   MUTAGEN      97     97       R->A: Abolishes interaction with NTRK3;
FT                                when associated with A-100.
FT                                {ECO:0000269|PubMed:25385546}.
FT   MUTAGEN     100    100       R->A: Abolishes interaction with NTRK3;
FT                                when associated with A-97.
FT                                {ECO:0000269|PubMed:25385546}.
FT   MUTAGEN     233    233       Y->S: Abolishes interaction with NTRK3.
FT                                {ECO:0000269|PubMed:25385546}.
FT   MUTAGEN     241    242       RR->AA: Decreases interaction with NTRK3.
FT                                {ECO:0000269|PubMed:25385546}.
FT   CONFLICT     48     48       G -> R (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    428    429       SA -> RP (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    742    745       RSPA -> LGPV (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT    765    766       GA -> RR (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    768    768       A -> G (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT    910    910       R -> P (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    995    995       L -> V (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT   1195   1196       SL -> TV (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT   1310   1313       Missing (in Ref. 3; AAC62834).
FT                                {ECO:0000305}.
FT   CONFLICT   1431   1431       S -> F (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT   1546   1546       E -> D (in Ref. 6; AAB21146).
FT                                {ECO:0000305}.
FT   CONFLICT   1587   1587       V -> A (in Ref. 6; AAB21146).
FT                                {ECO:0000305}.
FT   CONFLICT   1705   1705       N -> K (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   STRAND       31     37       {ECO:0000244|PDB:2YD3}.
FT   STRAND       42     45       {ECO:0000244|PDB:2YD3}.
FT   STRAND       50     60       {ECO:0000244|PDB:2YD3}.
FT   STRAND       63     68       {ECO:0000244|PDB:2YD3}.
FT   TURN         69     71       {ECO:0000244|PDB:4PBX}.
FT   STRAND       75     83       {ECO:0000244|PDB:2YD3}.
FT   HELIX        84     86       {ECO:0000244|PDB:2YD3}.
FT   STRAND       88     93       {ECO:0000244|PDB:2YD3}.
FT   TURN         98    101       {ECO:0000244|PDB:2YD3}.
FT   STRAND      103    111       {ECO:0000244|PDB:2YD3}.
FT   STRAND      114    125       {ECO:0000244|PDB:2YD3}.
FT   HELIX       127    129       {ECO:0000244|PDB:2YD3}.
FT   STRAND      136    139       {ECO:0000244|PDB:2YD3}.
FT   STRAND      144    147       {ECO:0000244|PDB:2YD3}.
FT   STRAND      152    154       {ECO:0000244|PDB:2YD3}.
FT   STRAND      157    159       {ECO:0000244|PDB:2YD3}.
FT   STRAND      165    170       {ECO:0000244|PDB:2YD3}.
FT   HELIX       177    179       {ECO:0000244|PDB:2YD3}.
FT   TURN        180    182       {ECO:0000244|PDB:2YD3}.
FT   STRAND      183    186       {ECO:0000244|PDB:2YD3}.
FT   STRAND      201    205       {ECO:0000244|PDB:2YD3}.
FT   HELIX       208    210       {ECO:0000244|PDB:2YD3}.
FT   STRAND      212    220       {ECO:0000244|PDB:2YD3}.
FT   STRAND      223    226       {ECO:0000244|PDB:2YD3}.
FT   STRAND      230    235       {ECO:0000244|PDB:2YD3}.
FT   STRAND      243    249       {ECO:0000244|PDB:2YD9}.
FT   STRAND      254    256       {ECO:0000244|PDB:4PBX}.
FT   STRAND      262    272       {ECO:0000244|PDB:2YD9}.
FT   STRAND      275    280       {ECO:0000244|PDB:2YD9}.
FT   STRAND      288    290       {ECO:0000244|PDB:2YD9}.
FT   STRAND      293    300       {ECO:0000244|PDB:2YD9}.
FT   STRAND      307    315       {ECO:0000244|PDB:2YD9}.
FT   STRAND      318    327       {ECO:0000244|PDB:2YD9}.
FT   STRAND      339    343       {ECO:0000244|PDB:4PBX}.
FT   STRAND      348    351       {ECO:0000244|PDB:4PBX}.
FT   STRAND      361    370       {ECO:0000244|PDB:4PBX}.
FT   STRAND      377    382       {ECO:0000244|PDB:4PBX}.
FT   STRAND      384    389       {ECO:0000244|PDB:4PBX}.
FT   STRAND      397    405       {ECO:0000244|PDB:4PBX}.
FT   STRAND      410    413       {ECO:0000244|PDB:4PBX}.
FT   STRAND      417    420       {ECO:0000244|PDB:4PBX}.
FT   STRAND      431    441       {ECO:0000244|PDB:4PBX}.
FT   STRAND      443    448       {ECO:0000244|PDB:4PBX}.
FT   STRAND      457    466       {ECO:0000244|PDB:4PBX}.
FT   HELIX       472    474       {ECO:0000244|PDB:4PBX}.
FT   STRAND      475    479       {ECO:0000244|PDB:4PBX}.
FT   STRAND      482    488       {ECO:0000244|PDB:4PBX}.
FT   STRAND      496    507       {ECO:0000244|PDB:4PBX}.
FT   STRAND      516    524       {ECO:0000244|PDB:4PBX}.
FT   STRAND      529    537       {ECO:0000244|PDB:4PBX}.
FT   STRAND      540    546       {ECO:0000244|PDB:4PBX}.
FT   STRAND      554    562       {ECO:0000244|PDB:4PBX}.
FT   TURN        563    565       {ECO:0000244|PDB:4PBX}.
FT   STRAND      569    573       {ECO:0000244|PDB:4PBX}.
FT   STRAND      577    581       {ECO:0000244|PDB:4PBX}.
FT   STRAND      589    598       {ECO:0000244|PDB:4PBX}.
FT   STRAND      601    605       {ECO:0000244|PDB:4PBX}.
FT   STRAND      609    612       {ECO:0000244|PDB:4PBX}.
FT   HELIX      1375   1377       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1378   1398       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1409   1412       {ECO:0000244|PDB:2FH7}.
FT   TURN       1414   1416       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1417   1419       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1429   1431       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1432   1434       {ECO:0000244|PDB:2FH7}.
FT   TURN       1442   1445       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1446   1454       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1457   1464       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1469   1471       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1472   1481       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1486   1489       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1493   1495       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1507   1513       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1516   1525       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1527   1538       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1545   1552       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1557   1560       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1562   1564       {ECO:0000244|PDB:4BPC}.
FT   HELIX      1565   1577       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1585   1594       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1595   1612       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1617   1625       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1635   1650       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1658   1660       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1661   1668       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1676   1678       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1679   1685       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1698   1701       {ECO:0000244|PDB:2FH7}.
FT   TURN       1703   1705       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1706   1708       {ECO:0000244|PDB:2FH7}.
FT   TURN       1718   1720       {ECO:0000244|PDB:2FH7}.
FT   TURN       1728   1730       {ECO:0000244|PDB:2FH7}.
FT   TURN       1731   1734       {ECO:0000244|PDB:4BPC}.
FT   STRAND     1737   1741       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1744   1746       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1750   1753       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1758   1760       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1761   1770       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1775   1778       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1782   1784       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1796   1798       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1800   1802       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1805   1814       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1816   1827       {ECO:0000244|PDB:2FH7}.
FT   TURN       1828   1830       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1833   1841       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1846   1848       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1854   1869       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1876   1884       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1885   1903       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1904   1906       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1908   1915       {ECO:0000244|PDB:2FH7}.
FT   TURN       1916   1918       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1926   1941       {ECO:0000244|PDB:2FH7}.
SQ   SEQUENCE   1948 AA;  217041 MW;  E8BFA76CA410C457 CRC64;
     MAPTWGPGMV SVVGPMGLLV VLLVGGCAAE EPPRFIKEPK DQIGVSGGVA SFVCQATGDP
     KPRVTWNKKG KKVNSQRFET IEFDESAGAV LRIQPLRTPR DENVYECVAQ NSVGEITVHA
     KLTVLREDQL PSGFPNIDMG PQLKVVERTR TATMLCAASG NPDPEITWFK DFLPVDPSAS
     NGRIKQLRSE TFESTPIRGA LQIESSEETD QGKYECVATN SAGVRYSSPA NLYVRELREV
     RRVAPRFSIL PMSHEIMPGG NVNITCVAVG SPMPYVKWMQ GAEDLTPEDD MPVGRNVLEL
     TDVKDSANYT CVAMSSLGVI EAVAQITVKS LPKAPGTPMV TENTATSITI TWDSGNPDPV
     SYYVIEYKSK SQDGPYQIKE DITTTRYSIG GLSPNSEYEI WVSAVNSIGQ GPPSESVVTR
     TGEQAPASAP RNVQARMLSA TTMIVQWEEP VEPNGLIRGY RVYYTMEPEH PVGNWQKHNV
     DDSLLTTVGS LLEDETYTVR VLAFTSVGDG PLSDPIQVKT QQGVPGQPMN LRAEARSETS
     ITLSWSPPRQ ESIIKYELLF REGDHGREVG RTFDPTTSYV VEDLKPNTEY AFRLAARSPQ
     GLGAFTPVVR QRTLQSKPSA PPQDVKCVSV RSTAILVSWR PPPPETHNGA LVGYSVRYRP
     LGSEDPEPKE VNGIPPTTTQ ILLEALEKWT QYRITTVAHT EVGPGPESSP VVVRTDEDVP
     SAPPRKVEAE ALNATAIRVL WRSPAPGRQH GQIRGYQVHY VRMEGAEARG PPRIKDVMLA
     DAQWETDDTA EYEMVITNLQ PETAYSITVA AYTMKGDGAR SKPKVVVTKG AVLGRPTLSV
     QQTPEGSLLA RWEPPAGTAE DQVLGYRLQF GREDSTPLAT LEFPPSEDRY TASGVHKGAT
     YVFRLAARSR GGLGEEAAEV LSIPEDTPRG HPQILEAAGN ASAGTVLLRW LPPVPAERNG
     AIVKYTVAVR EAGALGPARE TELPAAAEPG AENALTLQGL KPDTAYDLQV RAHTRRGPGP
     FSPPVRYRTF LRDQVSPKNF KVKMIMKTSV LLSWEFPDNY NSPTPYKIQY NGLTLDVDGR
     TTKKLITHLK PHTFYNFVLT NRGSSLGGLQ QTVTAWTAFN LLNGKPSVAP KPDADGFIMV
     YLPDGQSPVP VQSYFIVMVP LRKSRGGQFL TPLGSPEDMD LEELIQDISR LQRRSLRHSR
     QLEVPRPYIA ARFSVLPPTF HPGDQKQYGG FDNRGLEPGH RYVLFVLAVL QKSEPTFAAS
     PFSDPFQLDN PDPQPIVDGE EGLIWVIGPV LAVVFIICIV IAILLYKNKP DSKRKDSEPR
     TKCLLNNADL APHHPKDPVE MRRINFQTPD SGLRSPLREP GFHFESMLSH PPIPIADMAE
     HTERLKANDS LKLSQEYESI DPGQQFTWEH SNLEVNKPKN RYANVIAYDH SRVILQPIEG
     IMGSDYINAN YVDGYRCQNA YIATQGPLPE TFGDFWRMVW EQRSATIVMM TRLEEKSRIK
     CDQYWPNRGT ETYGFIQVTL LDTIELATFC VRTFSLHKNG SSEKREVRQF QFTAWPDHGV
     PEYPTPFLAF LRRVKTCNPP DAGPIVVHCS AGVGRTGCFI VIDAMLERIK PEKTVDVYGH
     VTLMRSQRNY MVQTEDQYSF IHEALLEAVG CGNTEVPARS LYAYIQKLAQ VEPGEHVTGM
     ELEFKRLANS KAHTSRFISA NLPCNKFKNR LVNIMPYEST RVCLQPIRGV EGSDYINASF
     IDGYRQQKAY IATQGPLAET TEDFWRMLWE NNSTIVVMLT KLREMGREKC HQYWPAERSA
     RYQYFVVDPM AEYNMPQYIL REFKVTDARD GQSRTVRQFQ FTDWPEQGVP KSGEGFIDFI
     GQVHKTKEQF GQDGPISVHC SAGVGRTGVF ITLSIVLERM RYEGVVDIFQ TVKMLRTQRP
     AMVQTEDEYQ FCYQAALEYL GSFDHYAT
//
